Impact of Testosterone Therapy on Hematocrit and Polycythemia: Evaluation of Data From Two Ongoing Open-Label Randomized Single-Center Clinical Trials

Introduction & Objective: Testosterone (T) replacement therapy (TRT) is the mainstay treatment for male hypogonadism. The most commonly reported adverse event among men using TRT is polycythemia. What is unknown is whether the short-acting vs. long-acting testosterone preparations have different...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Daniel, Kresch, Eliyahu, Ory, Jesse, Nackeeran, Sirpi, Blachman-Braun, Ruben, Molina, Manuel, Ramasamy, Ranjith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090421/
http://dx.doi.org/10.1210/jendso/bvab048.1544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090421/
http://dx.doi.org/10.1210/jendso/bvab048.1544

Ejemplares similares